On (b)(6) 2015, notification was received from the department of health & human services, food and drug administration (fda) that a user facility form (mw5039730) was submitted by the physician.The following is a description of what was reported by the physician: "home inr monitor registered 2.1.Patient developed bruising, headache, died in bed, autopsy showed large subdural hematoma.The inr manufacturer issued recall immediately after." the physician was contacted but would not release any information without permission of the patient's family.There is no information available to suggest a malfunction or that the device caused or contributed to the reported event.The patient's coagulation status was unknown at the time of death.Based on the inability to rule out the possibility that the device may have caused or contributed to the death, this event is conservatively reported as a death based on the autopsy showing a large subdural hematoma being potentially related to the patient's coagulation status; however, a device deficiency cannot be substantiated.
|
Investigation/conclusion: since the product(s) associated with the complaint was not returned and a lot number was not provided, manufacturing record review could not be performed and further investigation was not possible.There is no information available to suggest a malfunction or that the device caused or contributed to the reported event.The patient's coagulation status was unknown at the time of death.Based on the inability to rule out the possibility that the device may have caused or contributed to the death, this event is conservatively reported as a death based on the autopsy showing a large subdural hematoma being potentially related to the patient's coagulation status; however, a device deficiency cannot be substantiated.
|